Serena Mazzotta

411 total citations
12 papers, 109 citations indexed

About

Serena Mazzotta is a scholar working on Oncology, Hematology and Genetics. According to data from OpenAlex, Serena Mazzotta has authored 12 papers receiving a total of 109 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Hematology and 4 papers in Genetics. Recurrent topics in Serena Mazzotta's work include Multiple Myeloma Research and Treatments (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Cancer Treatment and Pharmacology (3 papers). Serena Mazzotta is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Cancer Treatment and Pharmacology (3 papers). Serena Mazzotta collaborates with scholars based in Italy and Lebanon. Serena Mazzotta's co-authors include Catia Bigazzi, Alessandro Mauro, F Balzola, Stefano Angelini, Silvia Baudo, Piero Galieni, Giovanni Albani, Maria Letizia Petroni, V. Bicchiega and Gaia Izzo and has published in prestigious journals such as Journal of Clinical Microbiology, British Journal of Haematology and International Journal of Cardiology.

In The Last Decade

Serena Mazzotta

10 papers receiving 103 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Serena Mazzotta Italy	5	48	47	42	21	13	12	109
Lianna J. Marks United States	7	31 0.6×	34 0.7×	39 0.9×	31 1.5×	24 1.8×	21	137
Claudia Mechi Italy	9	22 0.5×	35 0.7×	51 1.2×	49 2.3×	9 0.7×	12	149
Taylor Mills United States	8	56 1.2×	93 2.0×	17 0.4×	15 0.7×	24 1.8×	17	230
P. Hofmann Germany	6	29 0.6×	38 0.8×	9 0.2×	13 0.6×	10 0.8×	13	117
Cristina Calderón‐Cabrera Spain	8	38 0.8×	24 0.5×	31 0.7×	16 0.8×	38 2.9×	16	127
Ellen Fraint United States	5	16 0.3×	44 0.9×	19 0.5×	18 0.9×	11 0.8×	13	89
O. Casez France	2	12 0.3×	65 1.4×	21 0.5×	37 1.8×	5 0.4×	6	152
Virginie Kinet Belgium	7	13 0.3×	62 1.3×	18 0.4×	9 0.4×	10 0.8×	12	190
Maria Carbone Italy	5	20 0.4×	62 1.3×	13 0.3×	22 1.0×	11 0.8×	8	127
Silvia Presas‐Rodríguez Spain	8	12 0.3×	39 0.8×	49 1.2×	24 1.1×	6 0.5×	21	177

Countries citing papers authored by Serena Mazzotta

Since Specialization

Citations

This map shows the geographic impact of Serena Mazzotta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serena Mazzotta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serena Mazzotta more than expected).

Fields of papers citing papers by Serena Mazzotta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serena Mazzotta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serena Mazzotta. The network helps show where Serena Mazzotta may publish in the future.

Co-authorship network of co-authors of Serena Mazzotta

This figure shows the co-authorship network connecting the top 25 collaborators of Serena Mazzotta. A scholar is included among the top collaborators of Serena Mazzotta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serena Mazzotta. Serena Mazzotta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Galieni, Piero, et al.. (2024). Unmutated IGHV at diagnosis in patients with early stage CLL independently predicts for shorter follow-up time to first treatment (TTFT). Leukemia Research. 143. 107541–107541.

Vito, Luca Di, et al.. (2024). Management of vulnerable patient phenotypes and acute coronary syndrome mechanisms. International Journal of Cardiology. 415. 132365–132365. 1 indexed citations

Galieni, Piero, et al.. (2021). The detection of circulating plasma cells may improve the Revised International Staging System (R‐ISS) risk stratification of patients with newly diagnosed multiple myeloma. British Journal of Haematology. 193(3). 542–550. 19 indexed citations

Bigazzi, Catia, et al.. (2015). Circulating plasma cells in newly diagnosed symptomatic multiple myeloma as a possible prognostic marker for patients with standard‐risk cytogenetics. British Journal of Haematology. 170(4). 523–531. 27 indexed citations

Mazzotta, Serena. (2007). I neuroni specchio, l’empatia e la coscienza. 13(13). 185–209.

Mazzotta, Serena, Roberto Guerranti, Alessandro Gozzetti, et al.. (2006). Increased serum lactate dehydrogenase isoenzymes in Ph-negative chronic myeloproliferative diseases: A metabolic adaptation?. Hematology. 11(4). 239–244. 5 indexed citations

Mazzotta, Serena, Alessandro Gozzetti, Monica Bocchia, et al.. (2005). Low-dose thalidomide-induced agranulocytosis in a multiple myeloma patient treated at diagnosis. Leukemia & lymphoma. 46(12). 1837–1838. 1 indexed citations

Gozzetti, Alessandro, Albertina Fanelli, S Gentili, et al.. (2004). A novel t(6;7)(p24;q21) in a chronic myelocytic leukemia in complete cytogenetic remission after therapy with imatinib mesylate. Cancer Genetics and Cytogenetics. 148(2). 152–154. 3 indexed citations

Mazzotta, Serena, Silvia Gentili, M. Lenoci, et al.. (2004). Disseminated Mucormycosis in a Patient with Acute Myeloblastic Leukemia Misdiagnosed as Infection by Enterococcus faecium. Journal of Clinical Microbiology. 42(1). 487–489. 4 indexed citations

10.

Petroni, Maria Letizia, Giovanni Albani, V. Bicchiega, et al.. (2003). Body composition in advanced-stage Parkinson?s disease. Acta Diabetologica. 40(0). s187–s190. 37 indexed citations

11.

Lorusso, Vito, et al.. (1995). RESULTS OF A CLINICAL MULTICENTRIC RANDOMIZED PHASE-II STUDY OF NONSMALL CELL LUNG-CANCER TREATED WITH VINORELBINE CISPLATIN VERSUS VINORELBINE ALONE. International Journal of Oncology. 6(1). 65–8. 8 indexed citations

12.

Lorusso, Vito, Annamaria Catino, Mario Brandi, et al.. (1994). Cyclophosphamide, mitoxantrone and fluorouracil versus cyclophosphamide, mitoxantrone and fluorouracil plus lonidamine for the treatment of advanced breast cancer. A multicentric randomized clinical trial. 4. 767–772. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact